Biological response modifiers (BRM), chemotherapy, and activated cytotoxic leukocyte subsets: strategies for rational design of apheresis-based cancer immunotherapies.

H. C. Stevenson; H. G. Klein

Biological response modifiers (BRM), chemotherapy, and activated cytotoxic leukocyte subsets: strategies for rational design of apheresis-based cancer immunotherapies.

H. C. Stevenson, H. G. Klein

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	559-565
Number of pages	7
Journal	Progress in Clinical and Biological Research
Volume	337
State	Published - 1990
Externally published	Yes

ASJC Scopus subject areas

General Medicine

Cite this

@article{18e6f025acc5469fa757cc2b455669e7,

title = "Biological response modifiers (BRM), chemotherapy, and activated cytotoxic leukocyte subsets: strategies for rational design of apheresis-based cancer immunotherapies.",

author = "Stevenson, {H. C.} and Klein, {H. G.}",

year = "1990",

language = "English (US)",

volume = "337",

pages = "559--565",

journal = "Progress in Clinical and Biological Research",

issn = "0361-7742",

publisher = "John Wiley & Sons Inc.",

}

TY - JOUR

T1 - Biological response modifiers (BRM), chemotherapy, and activated cytotoxic leukocyte subsets

T2 - strategies for rational design of apheresis-based cancer immunotherapies.

AU - Stevenson, H. C.

AU - Klein, H. G.

PY - 1990

Y1 - 1990

UR - http://www.scopus.com/inward/record.url?scp=0025035145&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025035145&partnerID=8YFLogxK

M3 - Article

C2 - 2353018

AN - SCOPUS:0025035145

SN - 0361-7742

VL - 337

SP - 559

EP - 565

JO - Progress in Clinical and Biological Research

JF - Progress in Clinical and Biological Research

ER -

Biological response modifiers (BRM), chemotherapy, and activated cytotoxic leukocyte subsets: strategies for rational design of apheresis-based cancer immunotherapies.

ASJC Scopus subject areas

Other files and links

Cite this